Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, 61-701 Poznan, Poland.
Department of Medical Simulation, Poznan University of Medical Sciences, 61-701 Poznan, Poland.
Int J Mol Sci. 2022 Mar 21;23(6):3414. doi: 10.3390/ijms23063414.
Thyroid hemiagenesis (THA) is an inborn absence of one thyroid lobe of largely unknown etiopathogenesis. The aim of the study was to reveal genetic factors responsible for thyroid maldevelopment in two siblings with THA. None of the family members presented with congenital heart defect. The samples were subjected to whole-exome sequencing (WES) (Illumina, TruSeq Exome Enrichment Kit, San Diego, CA 92121, USA). An ultra-rare variant c.839C>T (p.Pro280Leu) in NKX2-5 gene (NM_004387.4) was identified in both affected children and an unaffected father. In the mother, the variant was not present. This variant is reported in population databases with 0.0000655 MAF (GnomAD v3, dbSNP rs761596254). The affected amino acid position is moderately conserved (positive scores in PhyloP: 1.364 and phastCons: 0.398). Functional prediction algorithms showed deleterious impact (dbNSFP v4.1, FATHMM, SIFT) or benign (CADD, PolyPhen-2, Mutation Assessor). According to ACMG criteria, variant is classified as having uncertain clinical significance. For the first time, NKX2-5 gene variants were found in two siblings with THA, providing evidence for its potential contribution to the pathogenesis of this type of thyroid dysgenesis. The presence of the variant in an unaffected parent, carrier of p.Pro280Leu variant, suggests potential contribution of yet unidentified additional factors determining the final penetrance and expression.
甲状腺半侧不发育症(THA)是一种先天的甲状腺一叶缺失,其病因学尚不完全清楚。本研究的目的是揭示导致两例 THA 患者甲状腺发育不良的遗传因素。所有家庭成员均未患有先天性心脏病。采集样本进行全外显子组测序(WES)(Illumina,TruSeq Exome Enrichment Kit,圣地亚哥,CA 92121,美国)。在两个受影响的孩子和一个未受影响的父亲中发现了 NKX2-5 基因(NM_004387.4)中 c.839C>T(p.Pro280Leu)的超罕见变异。在母亲中,未发现该变异。该变异在人群数据库中以 0.0000655 MAF(GnomAD v3,dbSNP rs761596254)报道。受影响的氨基酸位置中度保守(PhyloP 的正得分:1.364,phastCons:0.398)。功能预测算法显示有害影响(dbNSFP v4.1,FATHMM,SIFT)或良性(CADD,PolyPhen-2,Mutation Assessor)。根据 ACMG 标准,该变异被归类为具有不确定的临床意义。首次在两例 THA 患者中发现 NKX2-5 基因突变,为该类型甲状腺发育不良的发病机制提供了潜在的证据。该变异在未受影响的父母中存在,为携带 p.Pro280Leu 变异的携带者,提示潜在的未识别的其他因素可能对最终的外显率和表达有一定的贡献。